Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | IKBKB | O14920 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6152062 | 0.87 | MAPT (0.43) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6693760 | 0.85 | MEN1 (0.40) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL5105883 | 0.83 | ALDH1A1 (0.46) | MAPTHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL28573033 | 0.82 | PDK1 (0.41) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6151371 | 0.81 | ALDH1A1 (0.33) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6428039 | 0.81 | ALDH1A1 (0.42) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6428042 | 0.81 | ALDH1A1 (0.42) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6852251 | 0.80 | CNR1 (0.40) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6904037 | 0.79 | PDK1 (0.38) | MAPTHPGDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL5101279 | 0.78 | MAPT (0.47) | MAPTHPGDCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1585749-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2005-10-19 | — | — | EP | disclosed |
| US-6930208-B2 | 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones | BAYER CROPSCIENCE GMBH (DE) | 2005-08-16 | — | — | US | disclosed |
| EP-1547577-A1 | ANTIAGING COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-20040204320-A1 | 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones | BAYER CROPSCIENCE GMBH (DE) | 2004-10-14 | — | — | US | disclosed |
| WO-2004063198-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2004-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204320-A1 | 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones | CBR3, CBR1, CYP2E1 | MAPT 3893/4885HPGD 677/4885CYP1A2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.